Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Operating Expenses | 3,939 | 4,700 | 3,909 | 2,426 | 1,645 |
| Operating Income | -3,939 | -4,700 | -3,909 | -2,426 | -1,645 |
| Interest Expense | 30 | 24 | 16 | 0 | 0 |
| Other Income | -56 | 351 | -327 | -2 | -28 |
| Pre-tax Income | -4,025 | -4,374 | -4,251 | -2,428 | -1,674 |
| Net Income Continuous | -4,025 | -4,374 | -4,251 | -2,428 | -1,674 |
| Net Income | $-4,025 | $-4,374 | $-4,251 | $-2,428 | $-1,674 |
| EPS Basic Total Ops | -845.58 | -1,031.30 | -1,426.56 | -1,027.46 | -1,373.26 |
| EPS Basic Continuous Ops | -845.20 | -1,142.60 | -1,504.83 | -1,082.35 | -878.61 |
| EPS Diluted Total Ops | -845.58 | -1,031.30 | -1,426.56 | -1,027.46 | -1,373.26 |
| EPS Diluted Continuous Ops | -845.20 | -1,142.60 | -1,504.83 | -1,082.35 | -878.61 |
| EPS Diluted Before Non-Recurring Items | -779.61 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,924 | $-4,686 | $-3,895 | $-2,426 | $-1,644 |